As a part of the inflammatory tumor microenvironment, IL-1β can participate in the activation of NF-κB canonical pathway either directly (via p65) or in combination with other inflammatory factors, induce the positive feedback expression of various chemokines and inflammatory factors, and build a complex dynamic pro-tumor cycle [43]. This evidence concerns the gene IL1B and neoplasm.